Renal function and hemodynamics in recent onset type 1 diabetes mellitus in sprague dawley rats

Pharmacologyonline

Volumn 2, Issue , 2009, Pages 546-556

  Salman, Ibrahim M ^a   Sattar, Munavvar A ^a   Abdullah, Nor A ^b   Ameer, Omar Z ^a   Salman, Harith M ^c   Abdulla, Mohammed H ^a   Basri, Fathihah ^a   Hussain, Nur Jannah M ^a   Yam, Mun F ^a   Naidu, Sriramaneni R ^a   Anand Swarup, Kolla R L ^a   Rathore, Hassaan A ^a   Kazi, Raisa N ^a   Khan, Md Abdul Hye ^d   Johns, Edward J ^e  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF BAGHDAD   (Iraq)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Acute renal insufficiency; Diabetes mellitus; Renal function; Streptozotocin

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; GLOMERULUS FILTRATION RATE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SODIUM EXCRETION; SODIUM URINE LEVEL; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; URINE FLOW RATE;

EID: 70049083782     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ritz E, Stefanski A. Diabetic nephropathy in 11 diabetes. Am J Kidney Dis 1996;27(2):167-194.
2. Mozaffari MS, Warren BK, Russell CM, Schaffer SW. Renal function in the noninsulindependent diabetic rat: effects of unilateral nephrectomy. J Pharmacol Toxicol Methods 1997;37:197-203.
3. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998;352:213-219.
4. Janssen U, Phillips AO, Floege J. (1999) Rodent models of nephropathy associated with type II diabetes. J Nephrol 1999;12(3):159-172.
5. Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 2003;18:265-272.
6. Yin X, Zhang Y, Wu H, et al. Protective effect of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci 2004;95:256-266.
7. Yin XX, Zhang YD, Shen JP, et al. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. Acta Pharmacol Sin 2005;26(6):721-728.
8. Daniele SM, Arriaga S, Martínez, SM, et al. Onset and evolution of nephropathy in rats with spontaneous diabetes mellitus. J Physiol Biochem 2000;56(1):45-54.
9. Jian K, Fok E, Cam MC, Sambandam N, Yao J, Rodrigues B. Susceptibility of spontaneously hypertensive rats to the diabetogenic effects of streptozotocin. Can J Physiol Pharm 1996;74:1215-1221, 2000.
10. Patel KP, Zhang PL. Reduced renal sympathoinhibition in response to acute volume expansion in diabetic rats. Am J Physiol Regul Integr Comp Physiol 1994;267:R372-R379.
11. Kaul CL, Grewal RS. Increased urinary excretion of catecholamines and their metabolites in streptozotocin diabetic rat. Pharmacology 1980;21:223-228.
12. Fushimi H, Inoue T, Matsuyama Y, et al. Impaired catecholamine secretion as a cause of diabetic autonomic neuropathy. Diabetes Res Clin Pract 1988;4:303-307
13. Bak M, Thomsen K, Christiansen T, Flyvbjerg A. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J Am Soc Nephrol 2000;11:1287-1292.
14. Zanchetti A, Stella A. Cardiovascular diseases and the kidney: an epidemiological overview. J Cardiovasc Pharmacol 1999;33:S1-S6.
15. Vrbjar N, Strelkova S, Stefek M., Kyselova Z, Gajdosikova A. Effect of the pyridoindole antioxidant stobadine on sodium handling of renal Na, K-ATPase in rats with streptozotocin-induced diabetes. Acta Dibetol 2004;41:172-178.
16. Cooper ME, Allen TJ, Jerums G, Doyle AE. Accelerated progression of diabetic nephropathy in the spontaneously Hypertensive streptozotocin diabetic rats. Clin Exp Pharm Physiol 1986;13(9):655-662.
17. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology. Eur J Clin Pathol 2004;34:785-796.
18. Yamamoto Y, Maeshima Y, Kitayama H, et al. Tumstatin peptide, an inhibitor of angiogensis, prevent glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004;53:1831-1840.
19. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 2004;107:217-224.
20. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986;46:201-206.
21. Montilla P, Barcos M, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I. Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J Biochem Mol Biol 2005;38(5):539-544.
22. Nobrega MA, Fleming S, Roman RJ, Shiozawa M, Schlick N, Lazar J, Jacob, HJ. Initial characterization of a rat model of diabetic nephropathy. Diabetes 2004;53: 735-742.
23. Casey RG, Joyce M, Roche-Nagle G, Chen G, Boucher-Hayes D. (2005) Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease. J Surg Res 2005;123:176-181.
24. Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK Applied Therapeutics: The Clinical Use of Drugs, 8th ed. Philadelphia, PA: Lippincot Williams and Wilkins, 2005.
25. Boon NA, Colledge NR, Walker BR, Hunter JAA. Davidson's principle and practice of medicine, 20th ed. Philadelphia, PA: Churchill Livingstone Elsevier, 2006.
26. Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 1999;48:377-382.
27. Fine L. The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
28. Luippold G, Beilharz M, Mühlbauer B. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 2004;19:342-347.
29. Khan MAH, Sattar MA, Abdullah NA, Johns EJ. α1B-adrenoceptors mediate adrenergically-induced renal vasoconstrictions in rats with renal impairment. Acta Pharmacol Sin 2008;29(2):193-203.